FindTrial
Sign In

Role of fibrinogen in predicting complications in diabetes.

Association between Fibrinogen level in Type 2 Diabetes Mellitus patient with or without Microvascular complications

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/016823
Enrollment
134
Registered
2019-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

KASTURBA MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes mellitus patient without microvascular complications. 2. Type 2 diabetes mellitus patient with microvascular complications

Exclusion criteria

Exclusion criteria: 1. Clinical/Laboratory evidence of liver dysfunction 2. Malignancy 3. Cerebrovascular disease / Peripheral vascular disease 4. History of coagulation disease 5. Pregnancy 6. Patients with chronic kidney dysfunction 7. Patients not giving consent

Design outcomes

Primary

MeasureTime frame
Serum fibrinogen levels are found to be higher in T2DM with complications as compared to diabetic controls. Timepoint: Duration of diabetes mellitus—

Secondary

MeasureTime frame
Serum fibrinogen is an independent risk factor with high predicting power for microvascular complications in patients with T2DMTimepoint: Duration of diabetes mellitus—

Countries

India

Contacts

Public ContactRISHABH R K

KASTURBA MEDICAL COLLEGE

shi.sha@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026